Valuation: InterCure Ltd.

Capitalization 248M 0 215M 203M 184M 341M 21.48B 384M 2.4B 918M 9.84B 931M 911M 36.17B P/E ratio 2023
-3.41x
P/E ratio 2024 -4.01x
Enterprise value 381M 0 330M 311M 283M 523M 32.98B 589M 3.68B 1.41B 15.11B 1.43B 1.4B 55.53B EV / Sales 2023
0.86x
EV / Sales 2024 1.69x
Free-Float
60.4%
Yield 2023 *
-
Yield 2024 -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.86%
1 week-3.23%
Current month-7.77%
1 month-9.01%
3 months+1.50%
6 months-17.14%
Current year-12.21%
More quotes
1 week 514
Extreme 514
550.1
1 month 509.5
Extreme 509.5
583.9
Current year 458.4
Extreme 458.4
644.9
1 year 454.1
Extreme 454.1
964.6
3 years 395
Extreme 395
2,219
5 years 395
Extreme 395
3,100
10 years 124.58
Extreme 124.5792
6,317.95
More quotes
Manager TitleAgeSince
Chief Executive Officer 54 23/12/2019
Director of Finance/CFO 46 29/02/2020
Comptroller/Controller/Auditor 48 31/12/2013
Director TitleAgeSince
Director/Board Member 49 02/09/2015
Director/Board Member 65 13/12/2014
Chairman 54 12/02/2025
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.86%-3.23%-30.98%-74.28% 71.11M
+14.13%-.--% - - 951M
0.00%-9.28%-18.52%-66.15% 172M
+5.30%+9.45%+104.41%+39.00% 87.87M
0.00%+1.75%-70.10%-86.76% 59.12M
+1.60%-1.82%-53.27%-81.85% 54.29M
Average +3.36%-1.50%-13.69%-54.01% 232.52M
Weighted average by Cap. +9.99%-0.84%-7.30%-51.31%
See all sector performances

Financials

2023 2024
Net sales 356M 0 308M 291M 264M 488M 30.79B 550M 3.44B 1.32B 14.11B 1.33B 1.31B 51.86B 239M 0 207M 195M 177M 328M 20.69B 370M 2.31B 884M 9.48B 896M 877M 34.84B
Net income -61.96M -0 -53.74M -50.62M -46M -85.1M -5.37B -95.88M -599M -229M -2.46B -232M -228M -9.04B -67.8M -0 -58.81M -55.39M -50.33M -93.11M -5.87B -105M -656M -251M -2.69B -254M -249M -9.89B
Net Debt 94.35M 0 81.84M 77.09M 70.05M 130M 8.17B 146M 913M 349M 3.74B 354M 346M 13.76B 133M 0 115M 108M 98.55M 182M 11.5B 205M 1.28B 492M 5.27B 498M 488M 19.36B
More financial data * Estimated data
Logo InterCure Ltd.
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Employees
320
More about the company
Date Price Change Volume
23/06/25 521.30 ILa -0.86% 29,148
22/06/25 525.80 ILa -0.85% 25,697
19/06/25 530.30 ILa -0.11% 20,114
18/06/25 530.90 ILa -1.48% 28,920
17/06/25 538.90 ILa +0.04% 51,148

Delayed Quote TEL AVIV STOCK EXCHANGE, June 23, 2025 at 03:24 pm

More quotes

Net sales - Rate of surprise